Scale Faster.

From small/large molecule to personalized medicine, leverage the power of Pharma 4.0 & increase your speed to market.

Learn More

Meeting a Once in a 100-Year Challenge

Format: article

Topics: industry perspectives

2020 Year in Review

This last year has been a challenge for us all.  For the life sciences industry, 2020 has also been a year of historical, life changing moments and scientific advancement.  As COVID-19 spread across the world, our amazing healthcare professionals tended to sick patients in need while global pharma teams worked behind the scenes toward a safe and reliable vaccine that could end this pandemic.

Here at Apprentice, we couldn’t be prouder to be a part of the critical lab and manufacturing processes related to these efforts.  We have the honor of working shoulder-to-shoulder with amazing teams developing and manufacturing everything from COVID vaccines to life saving cancer therapies.

It’s been incredible to watch them use our intelligent platform to optimize batch yield and quality, perform remote FDA tours, improve reliability and reduce deviations through AR-driven guided workflows, better manage resources, offer just-in-time training, collaborate with subject matter experts or troubleshoot equipment issues in real-time, and much more.

As life science teams pushed vaccine development forward at an astonishing pace, our Apprentice teams and suite of solutions expanded just as rapidly so that we can continue to support these critical processes in a way that no one else can.  We have thoughtfully scaled our intelligent software platform and are dedicated to helping our clients use our solution to not only address today’s challenges, but streamline processes and better prepare for the years ahead.

 

2020 growth

 

As rounds of the first Pfizer-BioNTech and Moderna vaccines make it to our brave healthcare workers and the most at-risk members of our communities, we know that there are brighter days ahead.  We are incredibly thankful for the individuals who have worked tirelessly this year to keep us healthy, and deliver a safe, reliable COVID vaccine to market.

To all of our clients, partners, investors and friends, we wish you a safe, healthy and happy 2021!  We look forward to a successful year ahead.